PACS Group gets NYSE extension to Sept 2, 2025 for delinquent filings; amends credit agreement

PACS Group, Inc.

NYSE granted additional trading period through Sept 2, 2025 to file delinquent 10-Q (Sep 2024), 10-K (Dec 2024), and 10-Q (Mar 2025); max cure period Nov 19, 2025.
Amended credit agreement with Truist extends deadline for FY2024 audited financials to 195 days post-year-end (from 90), with possible further extension.
New covenant requires unrestricted cash and permitted investments of at least $100M until audited FY2024 financials delivered.
Delinquent filings due to ongoing independent investigation by Audit Committee (previously disclosed in NT 10-K/10-Q filings).
Company intends to file as soon as feasible, but no assurance of regaining compliance.

item 1.01item 2.03item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.